Evidence-based treatments (EBTs) are underutilized, and when they are adopted, problems with implementation can diminish their impact [5]. Thus, the National Institutes of Health (NIH) and the Institute of Medicine (IOM) have prioritized efforts to advance implementation science [6, 7]. These...